Skip to main content
HighlightsHighlights Archive

Media Monitoring: 11 – 17 April

By April 17, 2024No Comments

Diagnostic checks rolled out to 160 sites under CDC programme

  • Patients can now benefit from vital tests, checks and scans being delivered at 160 sites across England as part of the CDC programme.
  • Latest statistics show sites have already delivered more than 7 million tests, checks and scans across England.

 

Labour vows to fund NHS pledges by tackling tax dodgers

  • Labour is pledging to fund policies on the NHS and school breakfast clubs by boosting efforts to tackle tax dodgers.
  • Shadow chancellor Rachel Reeves says plans to give more money to tax officials would help raise £5bn a year.
  • It says it will also raise £2.6bn by closing “loopholes” in the government’s plans to abolish non-dom exemptions.

 

‘World first’ tampon-based at-home vaginal health screening kit now available at Boots

  • Gynaecological health startup Daye has announced that its diagnostic tampon, which provides a non-invasive method of screening your vaginal health at home, is now available to buy at Boots in the UK.
  • Daye redesigned the tampon, which the company says has long been overlooked as merely a menstrual care product, into an easy-to-use device for gynaelogical health screening.
  • Unlike traditional screening methods like swabs and speculums, Daye’s Diagnostic Tampon collects more vaginal fluid than a standard swab and covers the whole vaginal canal, ensuring improved reliability and patient comfort in detecting a range of infections says the company.

 

Life Sciences Vision Cancer Mission page now live

  • The Cancer Mission aims to make the UK a leading testbed for oncology innovation by accelerating the development and commercialisation of a new generation of cancer diagnostics and therapeutics, allowing patients to be diagnosed earlier and offered therapies specifically designed to target their cancer.

 

People-centred approach to tackling antimicrobial resistance: key principle of the Roadmap on antimicrobial resistance for the WHO European Region 2023–2030

  • A people-centred approach acknowledges the central role of individuals and communities in tackling AMR, and in helping to address weaknesses and gaps in current AMR efforts.
  • The document illustrates what a people-centred approach to AMR means, demonstrates its value, and compiles useful resources and tools for implementation.

 

Business-led schemes set to boost growth all over the UK, including in life sciences and health

  • The Innovate UK Launchpad programme gathers pace with £16 million funding being offered for 101 new projects.
  • The Innovate UK Launchpad programme supports clusters of small and medium-sized enterprises (SMEs) and the most innovative businesses to progress their ideas towards commercialisation, contributing to local economic growth.
  • Each Launchpad has been developed in collaboration with local leadership to strengthen innovation in targeted clusters across the UK.

 

UK ‘wasting Brexit freedoms’ as drug trials held back by red tape (paywall)

  • Declining numbers are ‘disappointing’ despite Britain’s potential to be global life science superpower.

 

The Monthly Diagnostics data for February 2024 can be found here.

  • The total number of patients waiting six weeks or more from referral for one of the 15 key diagnostic tests at the end of February 2024 was 334,900. This was 20.8%of the total number of patients waiting at the end of the month.
  • Nationally, the operational standard of less than 1% of patients waiting six weeks or more was not met this month.
  • Compared with February 2023 the total number of patients waiting six weeks or more decreased by 67,200 while the proportion of patients waiting six weeks or more decreased by 4.3 percentage points.
  • In the last 12 months, the proportion of patients waiting six weeks or more at the end of a month has varied between 20.8% (February 2024) and 27.6% (April 2023).
  • The estimated average time that a patient had been waiting for a diagnostic test was 2.8 weeks at the end of February 2024.
  • There were 1,611,800 patients waiting for a key diagnostic test at the end of February 2024. This is an increase of 10,300 from February 2023.
  • A total of 2,236,100 diagnostic tests were undertaken in February 2024. This is an increase of 175,300 from February 2023.

 

Ben Kemp